Pharmaceuticals

Global INR Testing Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID :Maia-19461069 | Published Date: 04-Nov-2021 | No. of pages: 123

Description

The specific blood test used to measure the time it takes for blood to clot is called a prothrombin time test, or protime (PT). The PT is reported as the International Normalized Ratio (INR). The INR is a calculation based on results of a PT test and is used to monitor individuals who are being treated with the anticoagulation medication warfarin.
The INR Testing market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global INR Testing market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the INR Testing Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in INR Testing market are:
Mayo Clinic
Lab Tests Online AU
Cleveland Clinic
Lincare Holdings
Health Call
mdINR
Premier Medical Group
Roche
Abbott
Calgary Laboratory Services (CLS)

Most important types of INR Testing products covered in this report are:
Laboratory Testing
Professional POC Testing

Most widely used downstream fields of INR Testing market covered in this report are:
Venous Blood Clots
Arterial Clots
Atrial Fibrillation
Mechanical Heart Valves

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.